TITLE

Management of Onychomycoses

AUTHOR(S)
Niewerth, M.; Korting, H.C.
PUB. DATE
August 1999
SOURCE
Drugs;Aug1999, Vol. 58 Issue 2, p283
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Onychomycoses, infections of the nail caused by fungi, are amongst the most common illnesses. Because of the high incidence of these infections and problems involved in their therapy, they have received much attention, particularly as concerns a better characterisation of the causative micro-organisms. Onychomycosis caused by dermatophytes (tinea unguium) is most common and is found more frequently on the feet than on the hands. The clinical presentation of onychomycosis is at best indicative of fungal infection, and the growth of a credible pathogen is an indispensable prerequisite for definite diagnosis. The clinical appearance is variable. Four major types of manifestation have been characterised, depending on localisation and spread. New antifungal agents for systemic or topical application based on novel active substances or vehicles are available, and cure is feasible for the majority of cases. Therapy can and should be individualised, depending on the characteristics of the particular case. Currently, continuous or intermittent oral treatment with itraconazole or terbinafine exhibit a particularly favourable risk : benefit ratio. Fluconazole might become an alternative in the near future. With respect to topical treatment, ciclopirox or amorolfine lacquer and the bifonazole/urea combination deserve particular interest. However, cure cannot be expected for every case.
ACCESSION #
9592862

 

Related Articles

  • Treating Onychomycosis. Rodgers, Phillip; Bassler, Mary // American Family Physician;2/15/2001, Vol. 63 Issue 4, p663 

    Onychomycosis accounts for one third of fungal skin infections. Because only about one half of nail dystrophies are caused by fungus, the diagnosis should be confirmed by potassium hydroxide preparation, culture or histology before treatment is started. Newer, more effective antifungal agents...

  • Onychomadesis in children: think about a late complication of hand-foot-mouth disease. Zaouak, Anissa; Bouhajja, Leila; Hammami, Houda; Fenniche, Samy // Our Dermatology Online / Nasza Dermatologia Online;Jan2020, Vol. 11 Issue 1, p41 

    Hand foot mouth disease (HFMD) is considered to be the most common infectious disease in association with onychomadesis. Coxsackie A6 may be the major subtype associated with onychomadesis after HFMD. A 2-year-old female child was referred to our department for an acute vesiculobullous eruption...

  • Diagnosis and treatment of fungal nail disease.  // American Family Physician;3/1/1996, Vol. 53 Issue 4, p1362 

    Reports on a study published in the 1995 issue of the `British Medical Journal' periodical by Denning et al who reviewed the clinical features, diagnosis and treatment of onychomycosis. Methodology of the study; Research design; Importance of accurate diagnosis and appropriate choice of agents...

  • Review of Clinical Trials of Topical Antifungal Therapy. Walling, Anne D. // American Family Physician;11/15/1999, Vol. 60 Issue 8, p2418 

    Presents an abstract of the study `Systematic Review of Topical Treatments for Fungal Infections of the Skin and Nails of the Feet,' by R. Hart et al., which appeared on the July 10, 1999 issue of the `British Medical Journal.'

  • Fungal nail dystrophy. Chittari, Kim; Ilchyshyn, Andrew // Update;Jul2007, Vol. 75 Issue 1, p21 

    The article presents information on the diagnosis and the topical and systemic antifungal therapy of nail infection. In onychomycosis, the concentration of fungus is highest in the nail bed. Sublingual debris should be collected from the most proximal and lateral portion of the affected nail bed...

  • Topical Solution for Nail Fungus. Preboth, Monica // American Family Physician;10/1/2001, Vol. 64 Issue 7, p1280 

    Reports on the approval of ciclopirox topical solution, 8 percent, for the treatment of onychomycosis by the United States Food and Drug Administration. Description of the solution and its use; Side effects.

  • Onychodystrophy as the only sign of congenital candidiasis. Joy Way Bueno, Susy M.; Santos Muñoz, Andrea; Maldonado, Ivana; Larralde, Margarita // Pediatric Dermatology;Jan2020, Vol. 37 Issue 1, p159 

    Congenital candidiasis infection often presents as a skin rash with variable involvement of nails and mucous membranes. Isolated nail involvement is rare, may present late, and can often be managed with topical antifungal medication. We report a case of congenital candidiasis limited to the...

  • Consider nail infections even with negative lab tests.  // Pulse;6/15/2011, Vol. 71 Issue 22, p10 

    The article reports on the study conducted by Israeli researchers who discovered that patients with suspected toenail onychomycosis and initially tested negative on fungal examination are found to have fungal infections after several more tests.

  • Nall Infection Treatment Holds Promise.  // MMR;9/15/2014, Vol. 31 Issue 15, p17 

    The article reports on the successful study of formulation to treat the onychomycosis fungal infections of the nail.

  • Treat onychomycosis topically or orally? Guzik, Joseph S.; H.C.N. // Cortlandt Forum;3/25/95, Vol. 8 Issue 3, p64 

    Presents suggestions for treating onychomycosis. Use of Mycocide (benzalkonium chloride) nail solution from Woodward Laboratories Inc.; Use of Naftin (naftifine hydrochloride) from Herbert Laboratories; Fluconazole.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics